New precision radiotherapy cuts hospital visits for prostate cancer patients
新型精準放射治療減少攝護腺癌患者回診次數
更新於: 2026年6月10日 上午06:00
Medical technology has reached a significant milestone in the fight against prostate cancer.
醫學技術在對抗攝護腺癌方面已達到重要的里程碑。
A modern approach called hypofractionated radiotherapy has emerged as a new standard of care, transforming the patient experience.
一種被稱為「分割放射治療」(hypofractionated radiotherapy)的現代方法已成為新的照護標準，徹底改變了病患的就醫體驗。
Today, advancements in precision imaging and linear accelerators allow doctors to deliver higher, more targeted doses of radiation in far fewer sessions, sometimes as few as five weeks or less.
如今，精準成像與線性加速器的進步，讓醫生能夠在少得多的療程中提供更高、更具標靶性的放射劑量，有時甚至短至五週或更短。
This innovation is a triumph of efficiency.
這項創新是效率的勝利。
Beyond the clinical success, the impact on quality of life is profound.
除了臨床成功之外，這對生活品質的影響也很深遠。
By drastically reducing the number of hospital trips, patients experience less disruption to their daily routines.
透過大幅減少往返醫院的次數，病患的日常作息受到的干擾更少。
While every treatment plan remains personalized, the adoption of hypofractionation represents a major leap forward, proving that medical progress is not just about new discoveries, but also about making existing, life-saving treatments more accessible and convenient for those who need them.
雖然每個治療計畫仍採個人化，但引進分割放射治療代表著重大的躍進，證明醫學的進步不僅在於新的發現，更在於讓現有的救命治療對需要的人來說更加容易獲取且更便利。
